News & Events category:
Manchester Royal Infirmary

A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.

Ground-breaking research taking place at Manchester University NHS Foundation Trust is investigating a pioneering new treatment for COVID-19.

The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.

A trainee surgeon at Manchester Royal Infirmary (MRI) was recently awarded a prestigious national honour for his contributions to transplant research.

Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.

Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.

Dr Stephanie Ling, Clinical Research Fellow at Manchester Royal Infirmary, discusses working with rheumatoid arthritis patients through research to improve biologic treatments.

A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.